UK Report Highlights Call for More Inclusive and Accessible Medicines Research and Care

A new UK report calls for more inclusive, accessible medicines research and healthcare practices, highlighting stakeholder insights on improving the entire medicines lifecycle from discovery to use.
A comprehensive new report released in the UK on June 23, 2025, underscores the urgent need to make medicines research and healthcare more inclusive and accessible for all. Led by researchers from the University of Liverpool, Manchester Metropolitan University, and University College London, the study engaged both the public and healthcare professionals through workshops and discussions to gather diverse perspectives on the entire lifecycle of medicines, from discovery to everyday use.
The report, titled "Better Medicines: Public and Professional Views on the Lifecycle from Discovery to Taking Medicines," reflects a wide range of insights across the healthcare and life sciences sectors, including experiences of patients, clinicians, researchers, industry experts, and regulators. It emphasizes that while there is widespread trust in the scientific advancements and safety processes, there are notable gaps and opportunities for improvement.
Key findings reveal that both the public and professionals agree on the significant positive impact of medicines on health outcomes and express admiration for the UK's publicly funded healthcare system. However, they also identify disparities and areas needing attention, such as reaching underrepresented groups, addressing regional inequalities, and tackling systemic barriers in research.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Why Everyone, Regardless of Skin Tone, Should Wear Sunscreen
Discover why wearing sunscreen is crucial for all skin tones to prevent skin damage, aging, and skin cancer. Learn the best practices for effective sun protection.
Quitting Smoking Enhances Recovery from Other Substance Use Disorders
Research shows that quitting smoking significantly improves the chances of recovery from other substance use disorders, highlighting the importance of integrated addiction treatment strategies.
Innovative Immunotherapy Approach Shows Long-Term Benefits in Advanced NSCLC Patients
A groundbreaking viral immunotherapy, CAN-2409, shows significant promise in extending survival for advanced NSCLC patients resistant to standard treatments, highlighting potential for future cancer immunotherapy strategies.



